Holen Sie sich die Stockscreener-App
0.418
4.76%
0.019
Handel nachbörslich:
.38
-0.038
-9.09%
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix Medical Inc. (AMIX) Edges Higher as Key Support Level HoldsSector Leader Stocks - Newser
AMIX Stock Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation - marketscreener.com
New Autonomix patent aims for real-time feedback in nerve procedures - Stock Titan
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation - Sahm
Why Is Autonomix Medical, Inc. Common Stock (AMIX) Stock Down Today? - Meyka
Autonomix Medical announces abstract acceptances at EuroPCR 2026 showcasing long-term data in pancreatic cancer pain mitigation - marketscreener.com
Autonomix Medical Announces Abstract Acceptances At Europcr 2026 Showcasing Long-Term Data In Pancreatic Cancer Pain Mitigation - TradingView
Autonomix Medical to present new pancreatic cancer pain relief data at EuroPCR 2026 in Paris - Pluang
Autonomix Medical Announces Abstract Acceptances at EuroPCR - GlobeNewswire
TradingKey - TradingKey
AMIX: Autonomix Medical, Inc.Interactive Chart - Zacks Investment Research
Number of shareholders of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
How Autonomix (AMIX) stacks up against analyst expectations (Flirts with Support) 2026-05-08Social Buzz Stocks - Newser
AMIX (Autonomix) EPS beats estimates by 39.7% but stock falls on zero revenue; investors eye commercialization timeline.Profitability - newser.com
AMIX Stock Price, Quote & Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
Autonomix Medical Announces Abstract Acceptance At Digestive Disease Week 2026 - TradingView
Pancreatic cancer pain study from Autonomix lands DDW 2026 slot - Stock Titan
AMIX Autonomix delivers narrower than expected Q1 2026 loss, shares fall 6.66 percent in today’s trading.Expert Momentum Signals - Newser
Autonomix (AMIX) Stock Factory Orders (+0.22%) 2026-04-27Change of Character - Newser
Autonomix (AMIX) Innovation Pipeline | Autonomix Medical posts narrower loss with 39.7% EPS surpriseATM Offering - Cổng thông tin điện tử Tỉnh Sơn La
Autonomix Medical shares rally on positive pancreatic cancer pain data - MSN
Is Autonomix (AMIX) stock cyclical or defensive | Q1 2026: EPS Exceeds ExpectationsMost Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Autonomix Medical, Inc. to Present Long-Term Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at ECIO 2026 - Quiver Quantitative
Long-term pancreatic cancer pain study from Autonomix gets Basel stage - Stock Titan
Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 - Yahoo Finance
Autonomix (AMIX) Stock: Forming Reversal? (-1.97%) 2026-04-20Risk Management - Xã Thanh Hà
Insider Trends: Can Autonomix Medical Inc scale operations efficiently2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
Insider Sell: What analysts say about Autonomix Medical Inc stockStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Autonomix Medical Inc meet Warren Buffetts criteria2026 Institutional Moves & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Jobs Data: Is Autonomix Medical Inc a potential multi bagger2026 Market Trends & High Return Stock Watch Alerts - baoquankhu1.vn
Autonomix Medical’s Featured Abstract on Pain Mitigation in Pancreatic Adenocarcinoma to be Presented at SIR 2026 Annual Scientific Meeting - Quiver Quantitative
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 - Weekly Voice
Autonomix Medical Selected for Featured Abstract and Podium - GlobeNewswire
Whale Trades: What are analysts price targets for Autonomix Medical IncAnalyst Downgrade & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Is Autonomix (AMIX) Stock Slowing Down | Price at $0.39, Down 1.14%Aggressive Growth Stocks - Newser
Market Outlook: How is Autonomix Medical Inc managing supply chain issues2026 Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
AMIX Stock Analysis: Autonomix Medical Inc. medtech stock at 0.4 gains 3.18 pct - Newser
Aug Big Picture: Is Autonomix Medical Inc a speculative investment2026 Action & High Accuracy Buy Signal Tips - baoquankhu1.vn
RSI Check: What analysts say about Autonomix Medical Inc stockQuarterly Risk Review & Safe Entry Point Identification - baoquankhu1.vn
Meme Stocks: Is Autonomix Medical Inc a potential multi bagger2026 Winners & Losers & Low Risk High Win Rate Picks - baoquankhu1.vn
Autonomix Medical, Inc.: Fundamental Analysis and Financial Ratings | AMIX | US05330T2050 - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Market Review: Is Autonomix Medical Inc a speculative investmentOptions Play & Technical Buy Zone Confirmation - baoquankhu1.vn
Hedge Fund Bets: Does Autonomix Medical Inc have a sustainable dividendQuarterly Profit Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Autonomix Medical (AMIX) Stock Price, News & Analysis - MarketBeat
Forecast Cut: Is Autonomix Medical Inc a speculative investment2026 Buyback Activity & Smart Investment Allocation Insights - baoquankhu1.vn
Autonomix Medical to Present at LSI USA '26 - marketscreener.com
Autonomix Medical to Present at LSI USA '26 Conference on Innovative Nerve-Targeted Treatments - Quiver Quantitative
Autonomix Medical to Present at LSI USA ’26 - GlobeNewswire
How is Autonomix Medical Inc managing supply chain issues2026 Bull vs Bear & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - The Globe and Mail
Autonomix Medical, Inc. Secures Oral Presentation Spot at CRT 2026 for Innovative Nerve-Targeted Technology - Quiver Quantitative
New nerve-targeting tech lands CRT 2026 Best Innovation stage - Stock Titan
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):